Boosting excellence - Strategic Partnership Initiative / Health Sciences and Technologies in Luxembourg / Portrait / Luxembourg BioHealth Cluster

Luxembourg Cluster Portal

Luxembourg – an attractive location for research, development and innovation

Luxembourg BioHealth Cluster

The Luxembourg Government has identified the fast-growing Healthcare Biotech sector as a key innovation driver to foster economic diversification ...

Luxembourg EcoInnovation Cluster

Luxembourg hosts a thriving eco-innovation sector. There are numerous eco-companies in the country...

Luxembourg ICT Cluster

The Luxembourg ICT Cluster is a network that supports the various actors in the field of ICT in Luxembourg with the goal of creating and developing new sustainable business opportunities.

Luxembourg Materials Cluster

Luxembourg’s strong track record in the manufacture and processing of many types of innovative materials is well proven with internationally renowned companies...

Luxembourg Space Cluster

The Luxembourg Space Cluster brings together renowned and highly specialised companies and public research organisations in order to develop specific technology topics...

Luxembourg Cluster Portal Luxembourg BioHealth Cluster Luxembourg EcoInnovation Cluster Luxembourg ICT Cluster Luxembourg Materials Cluster Luxembourg Space Cluster

Boosting excellence - Strategic Partnership Initiative

A Strategic Partnership Initiative between the Public Research Organisations of Luxembourg, namely the CRP Gabriel Lippmann, CRP Henri Tudor, CRP-Santé and the University of Luxembourg, and three world-renowned US Institutions, respectively the Translational Genomics Research Institute (TGen) of Phoenix, the Institute for Systems Biology (ISB) of Seattle and the Partnership for Personalized Medicine (PPM) of Phoenix, was launched in 2008 with the aim of boosting the development in Luxembourg as a centre of excellence in the area of Molecular Medicine..This initiative has subsequently resulted in the creation of two key infrastructures and the implementation of one demonstration project:

Whereas the IBBL acts as a centerpiece gathering biotechnology and bioinformatics capabilities able to provide an integrated portfolio of services dealing with sample collection to data analysis, the LCSB and its three research units (Experimental Neurobiology, Computational Biology and Metabolomics) unravel, in an innovative way, the complex mechanisms of Parkinson’s disease and diabetes. In parallel to the collaborative project on lung cancer biomarker discovery, the CRP Santé is also developing a health economics approach to evaluate the costs of current lung cancer treatment in Luxembourg.